SCHEMBL7810309

SCHEMBL7810309

O=C1c2ccncc2-c2n[nH]c3cccc1c23

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 3/20 0.72
▸ CLK2 P49760 3/20 0.72
▸ DYRK1A Q13627 3/20 0.72
▸ PIM1 P11309 3/20 0.72
▸ MAPK8 P45983 2/20 0.72
▸ MAPK9 P45984 2/20 0.72
▸ MAPK10 P53779 2/20 0.72
▸ CDK2 P24941 2/20 0.72
▸ MAPK1 P28482 2/20 0.72
▸ CYP3A4 P08684 2/20 0.72
▸ PABPC1 P11940 2/20 0.72
▸ CASP1 P29466 2/20 0.72
▸ CASP7 P55210 2/20 0.72
▸ KIT P10721 2/20 0.72
▸ KDR P35968 2/20 0.72
▸ FLT3 P36888 2/20 0.72
▸ KDM4E B2RXH2 1/20 0.72
▸ MEN1 O00255 1/20 0.72
▸ CDC7 O00311 1/20 0.72
▸ PLK4 O00444 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817760 0.94 PIM1 (0.72) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL170980 0.84 ALDH1A1 (1.00) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL29693577 0.84 ALDH1A1 (1.00) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL29941507 0.84 ALDH1A1 (1.00) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL8866586 0.83 TTK (0.73) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL9201258 0.76 MEN1 (0.67) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL8796647 0.76 MEN1 (0.67) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL9115256 0.74 TTK (0.64) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL8336855 0.72 CDK2 (0.65) TTKCLK2DYRK1APIM1MAPK8
SCHEMBL1296328 0.72 TTK (0.65) TTKCLK2DYRK1APIM1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 — — EP claimed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 — — WO claimed
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 — — EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 — — EP disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 — — US disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 — — US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 — — US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 — — EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 — — US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 — — WO disclosed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 — — EP disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 — — WO disclosed
Send feedback